Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
765.410.07%
QQQ
717.380.14%
BTC/USD
79478.391.3069%
DIA
527.560.09%
GLD
398.850.22%
TLT
82.140.07%

Abeona Therapeutics Inc

ABEONASDAQ
Trade with Public
Trade with Public
$5.85
-0.15-2.5%
At close: Sep 4, 5:00 PM EST
$5.86
-0.14-2.33%
Pre-Market: 3:00 AM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Abeona Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for Abeona Therapeutics (ABEO).

Price Target Range — 10 Quarters

Analyst Consensus — 4 Analysts

4Buy
Consensus RatingOutperform# Analysts4Avg. Consensus PT$19Upside to Avg. PT+216.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 14, 2026OppenheimerJeff JonesPT CutOutperform$22→$21
May 28, 2026HC Wainwright & Co.Raghuram SelvarajuMaintainedBuy$20
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Oppenheimer Maintains Outperform on Abeona Therapeutics, Lowers Price Target to $21

Oppenheimer analyst Jeff Jones maintains Abeona Therapeutics (NASDAQ:ABEO) with a Outperform and lowers the price target from $22 to $21.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Abeona Therapeutics, Maintains $20 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and maintains $20 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Abeona Therapeutics, Maintains $20 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and maintains $20 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Abeona Therapeutics, Maintains $20 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and maintains $20 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Abeona Therapeutics, Maintains $20 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and maintains $20 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Abeona Therapeutics, Maintains $20 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and maintains $20 price target.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved